Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

What cost weight loss?

Hiatt WR, Thomas A, Goldfine AB.

Circulation. 2012 Mar 6;125(9):1171-7. doi: 10.1161/CIRCULATIONAHA.111.023499. No abstract available.

2.

Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit.

Cunningham JW, Wiviott SD.

Clin Cardiol. 2014 Nov;37(11):693-9. doi: 10.1002/clc.22304. Epub 2014 Sep 15. Review.

3.

Two anti-obesity hopefuls and their safety.

Bello NT, Campbell SC.

Expert Opin Drug Saf. 2012 Sep;11(5):681-3. doi: 10.1517/14740338.2012.706277. Epub 2012 Jul 13. No abstract available.

PMID:
22788876
4.

2 new drugs for weight loss.

[No authors listed]

Med Lett Drugs Ther. 2012 Sep 3;54(1398):69-71. No abstract available. Erratum in: Med Lett Drugs Ther. 2012 Sep 17;54(1399):76.

PMID:
22992487
5.
6.

Obesity Epidemic: Pharmaceutical Weight Loss.

Curry SA.

R I Med J (2013). 2017 Mar 1;100(2):18-20.

PMID:
28246654
7.

Drug treatment of obesity.

Smith SR.

JAMA Intern Med. 2014 Aug;174(8):1414-5. doi: 10.1001/jamainternmed.2014.1646. No abstract available.

PMID:
25090179
8.

Drug treatment of obesity.

Kyle TK, Nadglowski J Jr.

JAMA Intern Med. 2014 Aug;174(8):1414. doi: 10.1001/jamainternmed.2014.1640. No abstract available.

PMID:
25090178
9.

Drug treatment of obesity--reply.

Schwartz LM, Woloshin S.

JAMA Intern Med. 2014 Aug;174(8):1415-6. doi: 10.1001/jamainternmed.2014.1635. No abstract available.

PMID:
25090180
10.

Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management.

Fujioka K, Braverman-Panza J.

J Fam Pract. 2016 Jul;65(7 Suppl):S16-23.

PMID:
27565106
11.

Topiramate and phentermine: a long story....

[No authors listed]

Prescrire Int. 2013 Mar;22(136):62. No abstract available.

PMID:
23593687
12.

Combination phentermine and topiramate for weight maintenance: the first Australian experience.

Neoh SL, Sumithran P, Haywood CJ, Houlihan CA, Lee FT, Proietto J.

Med J Aust. 2014 Aug 18;201(4):224-6.

PMID:
25164851
13.

Contrave--a combination of bupropion and naltrexone for weight loss.

[No authors listed]

Med Lett Drugs Ther. 2014 Nov 10;56(1455):112-4. No abstract available.

PMID:
25372849
14.

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S.

JAMA. 2016 Jun 14;315(22):2424-34. doi: 10.1001/jama.2016.7602. Review. Erratum in: JAMA. 2016 Sep 6;316(9):995.

15.

Tolerability and safety of the new anti-obesity medications.

Hainer V, Aldhoon-Hainerov√° I.

Drug Saf. 2014 Sep;37(9):693-702. doi: 10.1007/s40264-014-0206-3. Review.

PMID:
25096956
16.

Phentermine plus topiramate in the treatment of obesity.

Malgarini RB, Pimpinella G.

Lancet. 2011 Jul 9;378(9786):125-6; author reply 126-7. doi: 10.1016/S0140-6736(11)61080-5. No abstract available.

PMID:
21742167
17.

Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.

Bays H.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16. Review.

PMID:
20707765
18.

Lorcaserin and phentermine/topiramate: two leaps forward in weight loss pharmacotherapy.

Hill LG.

Ann Pharmacother. 2013 Dec;47(12):1740. doi: 10.1177/1060028013513557. No abstract available.

PMID:
24396110
19.

Response to "lorcaserin and phentermine/topiramate: two leaps forward in weight loss pharmacotherapy".

Fleming JW, McClendon KS, Riche DM.

Ann Pharmacother. 2013 Dec;47(12):1741. doi: 10.1177/1060028013513884. Epub 2013 Dec 5. No abstract available.

PMID:
24311729
20.

New obesity agents: lorcaserin and phentermine/topiramate.

Fleming JW, McClendon KS, Riche DM.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16. doi: 10.1345/aph.1R779. Epub 2013 Jun 25. Review.

PMID:
23800750

Supplemental Content

Support Center